Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Treasury Shares (2021 - 2025)

Prime Medicine (PRME) has disclosed Treasury Shares for 5 consecutive years, with $3.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares changed 0.0% year-over-year to $3.5 million, compared with a TTM value of $3.5 million through Dec 2025, changed 0.0%, and an annual FY2025 reading of $3.5 million, changed 0.0% over the prior year.
  • Treasury Shares was $3.5 million for Q4 2025 at Prime Medicine, roughly flat from $3.5 million in the prior quarter.
  • Across five years, Treasury Shares topped out at $4.6 million in Q4 2021 and bottomed at $3116.0 in Q2 2022.
  • Average Treasury Shares over 5 years is $2.3 million, with a median of $3.5 million recorded in 2024.
  • The sharpest move saw Treasury Shares tumbled 99.75% in 2022, then surged 73970.51% in 2023.
  • Year by year, Treasury Shares stood at $4.6 million in 2021, then crashed by 99.75% to $11160.0 in 2022, then surged by 34243.81% to $3.8 million in 2023, then fell by 9.4% to $3.5 million in 2024, then changed by 0.0% to $3.5 million in 2025.
  • Business Quant data shows Treasury Shares for PRME at $3.5 million in Q4 2025, $3.5 million in Q3 2025, and $3.5 million in Q2 2025.